Merck’s Roger Perlmutter makes a rare move, joining the board of a machine learning startup out to change the R&D world. And he has some thoughts on that

Back in 2013, after a stint running R&D at Amgen followed by some independent time roaming the industry, Roger Perlmutter rejoined Merck and dedicated himself entirely to restoring the glean to the pharma giant’s tarnished rep. And one of the first things he did was shed his board memberships on…